EUVIMEDEUVIMED entdecken
Crossref

Phloretin alleviates renal injury in streptozotocin-induced diabetic mice through NF-κB/MAPK signaling pathways

Xiaoshan Xu, Chunshui Gong, Xiaoyan Bian

General physiology and biophysics · 2026 · 45 (04) · 397-407

DOI: 10.4149/gpb_2026013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift General physiology and biophysics, 2026. Verfasst von Xiaoshan Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ningde Municipal Hospital, Ningde City, Fujian Province, China. Hauptthemen laut MEDLINE: NF-kappa B, Phloretin, Diabetic Nephropathies, Diabetes Mellitus, Experimental.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a complication of diabetes characterized by renal dysfunction, fibrosis, and inflammation. This study aimed to investigate the nephroprotective effects of phloretin (PHL) in a streptozotocin (STZ)-induced diabetic mouse model. Mice were treated with PHL (50 mg/kg/day) for eight weeks, after which renal function parameters, oxidative stress markers, histopathological changes, fibrosis- and inflammation-related protein expression, and key signaling pathways were analyzed. The results demonstrated that PHL ameliorated hyperglycemia, renal dysfunction (as evidenced by reduced BUN, serum creatinine, and urinary albumin), and dyslipidemia (lowered serum TG and TC). PHL also attenuated renal oxidative stress by enhancing antioxidant enzyme activities (SOD, CAT, GSH-Px) and reducing lipid peroxidation (MDA). Histopathological evaluation revealed that PHL alleviated glomerular damage, tubular necrosis, and inflammatory cell infiltration, while Masson's staining showed inhibition of renal interstitial fibrosis. Mechanistically, PHL downregulated the expression of fibrosis markers (fibronectin, collagen I, α-SMA) and proinflammatory cytokines (IL-6, IL-1β, TNF-α). Furthermore, PHL suppressed the activation of the NF-κB and MAPK pathways, as indicated by increased IκBα levels and reduced phosphorylation of NF-κB p65, p38, JNK, and ERK1/2. In conclusion, PHL protects against DN by improving renal function, reducing oxidative stress, mitigating fibrosis and inflammation, and inactivating the NF-κB/MAPK pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BPhloretinDiabetic NephropathiesDiabetes Mellitus, ExperimentalMAP Kinase Signaling SystemAnimalsMiceMaleOxidative StressKidneyStreptozocinTreatment Outcome

Substanzen

NF-kappa BPhloretinStreptozocin

Autor:innen und Institutionen

  • Department of Nephrology, Ningde Municipal Hospital, Ningde City, Fujian Province, China.
  • Department of Nephrology, Xiamen Humanity Hospital, Huli District, Xiamen, Fujian Province, China.

Zitieren

APA

Xu, X., Gong, C., & Bian, X. (2026). Phloretin alleviates renal injury in streptozotocin-induced diabetic mice through NF-κB/MAPK signaling pathways. General physiology and biophysics, 45(04), 397-407. https://doi.org/10.4149/gpb_2026013

Vancouver

Xu X, Gong C, Bian X. Phloretin alleviates renal injury in streptozotocin-induced diabetic mice through NF-κB/MAPK signaling pathways. General physiology and biophysics. 2026;45(04):397-407. doi:10.4149/gpb_2026013

BibTeX
@article{Xu2026,
  author = {Xu, Xiaoshan and Gong, Chunshui and Bian, Xiaoyan},
  title = {Phloretin alleviates renal injury in streptozotocin-induced diabetic mice through NF-κB/MAPK signaling pathways},
  journal = {General physiology and biophysics},
  year = {2026},
  volume = {45},
  number = {04},
  pages = {397--407},
  doi = {10.4149/gpb_2026013}
}
Kostenlos starten →